Linkage, association and mutational analysis of the dopamine D3 receptor gene in schizophrenia

Molecular Psychiatry

Volumn 1, Issue 2, 1996, Pages 125-132

  Asherson, P ^a   Mant, R ^a   Holmans, P ^a   Williams, J ^a   Cardno, A ^a   Murphy, K ^a   Jones, L ^a   Collier, D ^b   McGuffin, P ^a   Owen, M J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Association study; DRD3; Linkage analysis; Mutation detection; Schizophrenia

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DRD3 PROTEIN, HUMAN;

ARTICLE; EXON; GENETIC LINKAGE; GENETICS; HUMAN; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; SCHIZOPHRENIA;

BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; EXONS; HUMANS; LINKAGE (GENETICS); MOLECULAR SEQUENCE DATA; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SCHIZOPHRENIA;

EID: 0030133294     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Carlsson A. The dopamine theory revisited. In: Hirsch SR, Weinberger DR (eds). Schizophrenia. Blackwell Science Ltd, University Press: Cambridge, 1995, pp 379-400.
2. Owen F, Simpson MDC. The neurochemistry of schizophrenia. In: Hirsch SR, Weinberger DR (eds). Schizophrenia. Blackwell Science Ltd, University Press: Cambridge, 1995, pp 358-378.
3. Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC. Molecular cloning and characterisation of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 1990; 347: 146-151.
4. Giros B, Martres MP, Sokoloff P, Schwartz JC. cDNA cloning of the human dopaminergic D3 dopamine receptor and chromosomal identification. CR Acad Sci Paris 1990; 311: 501-508.
5. Buckland PR, O'Donovan M, McGuffin P. Changes in dopamine D1, D2 and D3 receptor mRNA levels in rat brain following antipsychotic treatment. Psychopharmacology 1992; 106: 479-483.
6. Buckland PR, O'Donovan M, McGuffin P. Clozapine and sulpiride up-regulate dopamine D3 receptor mRNA levels. Neuropharmacology 1993; 32; 901-907.
7. Lannfelt L, Sokoloff P, Martres MP et al. Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders. Psychiatric Gen 1993; 2: 16.
8. Crocq MA, Mant R, Asherson P, Williams J, Hode Y, Mayerova A, Collier D, Lannfelt L, Sokoloff P, Schwartz JC et al. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Gen (Neuropsy Gen) 1992; 29(12): 858-860.
9. Mant R, Williams J, Asherson P, Parfitt E, McGuffin P, Owen MJ. Relationship between homozygosity at the dopamine D3 receptor gene and schizophrenia. Am J Med Gen (Neuropsy Gen) 1994; 54: 21-26.
10. Williams J, Mant R, Holmans P, McGuffin P, Owen M. A haplotype relative risk association study of the D3 receptor gene and highly familial schizophrenia and bipolar disorder. Psychiat Gen 1995; 5 (Supplement 1): 27.
11. Griffon N, Crocq MA, Pilon C, Martres MP, Mayerova G, Uyanik G, Burgert E, Duval F, Macher JP, Javoy-Agrid F, Tamminga CA, Schwartz JC, Sokoloff P. Dopamine D3 receptor gene: organization, transcript variants and polymorphism associated with schizophrenia. Am J Med Gen (Neuropsy Gen) 1996; 67: 63-70.
12. Gill M, McGuffin P, Parfitt E, Mant R, Asherson P, Collier D et al. A linkage study of schizophrenia with DNA markers from the long arm of chromosome 11. Psychol Med 1993; 23: 27-44.
13. Wing J, Cooper J, Sartorius N. The measurement and classification of psychiatric symptoms. Cambridge: Cambridge University Press, 1974.
14. McGuffin P, Farmer AE, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness: development and reliability of the OPCRIT system. Arch Gen Psychiat 1991; 48: 764-770.
15. Spitzer RL, Endicott J, Robins E. Research diagnostic criteria: rational and reliability. Arch Gen Psychiat 1978; 35: 773-782.
16. McGuffin P, Festenstein W, Murray RM. A family study of HLA antigens and other genetic markers in schizophrenia. Psychol Med 1983; 13: 31-43.
17. Clerget-Darpoux F. Effects of misspecifying genetic parameters in lod score-analysis. Biometrics 1986; 42: 393-399.
18. Lathrop G, Lalouel J, Julier C, Ott J. Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci USA 1984; 13: 31-43.
19. Ott J. Analysis of Human Genetic Linkage, 2nd edn. John Hopkins University Press: Baltimore, 1991.
20. Sandkuijl LA. Analysis of affected sib-pairs using information from extended families. In: Elston RC, Spence MA, Hodge SE, MacCluer JW (eds). Multipoint Mapping and Linkage Based upon Affected Pedigree Members. Genetic Analysis Workshop 6. Alan R Liss: New York, 1992.
21. Wing J, Babor T, Brugha T et al. SCAN: schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiat 1990; 47: 589-593.
22. Holmans P, Clayton D. Efficiency of typing unaffected relatives in an affected sib-pair linkage study with single locus and multiple tightly linked markers. Am J Hum Gen 1995; 57: 1221-1232.
23. Weissenbach J, Gypay G, Dib C, Vignal A, Morisette J, Millasseau P, Vaysseix G, Lathrop M. A second generation linkage map of the human genome. Nature 1992; 359: 794-801.
24. Coon H, Byerley W, Holik J, Hoff M, Myles-Worsley M, Lannfelt L, Sokoloff P, Schwartz JC, Waldo M, Freedman R, Plaetke R. Linkage analysis between schizophrenia and 5 dopamine receptors. Am J Hum Gen 1993; 52: 327-334.
25. Wiese C, Lannfelt L, Kristbjarnarson H, Yang L, Zoega T, Sokoloff P, Ivarsson O, Schwartz JC, Moises HW, Helgason T. No evidence of linkage between schizophrenia and D(3) dopamine receptor gene locus in Icelandic pedigrees. Psychiatry Res 1993; 46: 69-78.
26. Sabate O, Campion D, d'Amato T, Martres M-P, Sokoloff P, Giros B, Leboyer M, Jay M, Guedji F, Thibaut F et al. Failure to find evidence for linkage or association between the dopamine D3 receptor gene and schizophrenia. Am J Psychiatry 1994; 151(1): 107-111.
27. Asherson P, Parfitt E, Sargeant M, Taylor C et al. Failure to find linkage between schizophrenia and genetic markers on chromosome 21. Am J Med Gen (Neuropsy Gen) 1992; 48: 161-165.
28. Parfitt E, Asherson P, Roberts E, Mant R, Nanko S, Gill M, McGuffin P, Owen MA. No evidence for linkage between schizophrenia and 8 microstellite markers on chromosome. Hum Hered 1996; (in press).
29. Davies J, Kawaguchi Y, Bennett S, Copeman J, Heather C et al. A genome-wide search for human type I diabetes susceptibility genes. Nature 1994; 371: 130-136.
30. Nimgaonkar VL, Zhang XR, Caldwell JG, Ganguli R, Chakravarti A. Association with the dopamine D3 receptor gene locus among schizophrenic patients with a family history of schizophrenia. Am J Med Gen (Neuropsy Gen) 1993; 53; 838.
31. Jonssen E, Lannfelt L, Sokoloff P, Schwartz JC, Sedvall G. Lack of association between schizophrenia and alleles in the dopamine D3 receptor gene. Acta Psychiat Scand 1993; 87: 345-349.
32. Nimgaonkar VL, Zhang XR, Brar JS, Hogge WA, Ganguli R, Chakravati A. Dopamine D3 receptor gene locus: association with schizophrenia, as well as age of onset. Am J Hum Gen 1994; 55: 3-A160.
33. Shaikh S, Collier D, Sham P, Ball D, Aitchison K, Vallada H, Smith I, Gill M, Kerwin R. Allelic association between a Ser-9-Gly polymorphism in the dopamine D3 receptor gene and schizophrenia. 1996; Human Genetics (in press).
34. Ebstein RP, Macciardi F, Blaine D, Nemanov L, Gur E, Avnon M, Belmaker RH, Lerer B. Positive association between a DRD3 exon 1 polymorphism (Mscl) and schizophrenia in an Israeli non-Ashkenazi population. Psychiat Gen 1995; supplement 1, S13.
35. Nothen MM, Cichon S, Propping P, Fimmers R, Schwab SG, Wildenauer DB. Excess of homozygosity at the dopamine D3 receptor gene in schizophrenia not confirmed. J Med Gen 1993; 30: 708-712.
36. Yang L, Wiese C, Llanfelt L, Sokoloff P, Xu CT, Zeng Z, Schwartz JC, Liu XH, Moises HW. No association between schizophrenia and homozygosity at the D3 dopamine receptor gene. Am J Med Gen (Neuropsy Gen) 1993; 48: 83-86.
37. Nanko S, Sasaki T, Fukuda R, Hattori M, Dai XY, Kazamatsuri H, Kuwata S, Juji T, Gill M. A study of the association between schizophrenia and the dopamine D3 receptor gene. Hum Gen 1993; 92: 336-338.
38. Laurent C, Savoye C, Samolyk D, Meloni R, Mallet J, Campion D, Martinez M et al. Homozygosity at the dopamine D3 receptor locus is not associated with schizophrenia. J Med Gen 1994; 31: 260.
39. Green SA, Turki J, Innis M, Liggett SB. Amino-terminal polymorphisms of the human beta2 adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994; 33: 9414-9419.
40. Park B-H, Fishburn CS, Carmon S, Accili D, Fuchs S. Structural organization of the murine D3 dopamine receptor gene. J Neurochem 1995; 64: 482-486.
41. Accili D, Fishburn S, Drago J, Steiner H, Lachowicz J, Park B-H, Gauda E, Lee E, Cool M, Sibley D, Gerfen G, Westphal H, Fuchs S. A targeted mutation of the dopamine D3 receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci USA 1996; 93: 1945-1949.